EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2

Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III

(2013) D. R. Emlet et al.   CANCER RESEARCH

Epidermal Growth Factor (EGF)-enhanced Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion

(2013) Yanhua Zheng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

EGF signalling and rapamycin-mediated mTOR inhibition in glioblastoma multiforme evaluated by phospho-specific flow cytometry

(2013) Isabelle Cornez et al.   JOURNAL OF NEURO-ONCOLOGY

Genomics informs glioblastoma biology

(2013) David L Schonberg et al.   NATURE GENETICS

Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

(2013) Xi-Ping Tang   WORLD JOURNAL OF GASTROENTEROLOGY

Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA

(2012) Antony Prabhu et al.   PLoS One

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240

(2012) T. R. Fenton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells

(2011) J. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53

(2010) Binghui Li et al.   CANCER LETTERS

Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells

(2010) Jie Liu et al.   FITOTERAPIA

Genetic variations in EGF and EGFR and glioblastoma outcome

(2010) S. Sjostrom et al.   NEURO-ONCOLOGY

EGF receptor inhibitors in the treatment of glioblastoma multiform: Old clinical allies and newly emerging therapeutic concepts

(2009) Macoura Gadji et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activity and cellular localization of an oncogenic glioblastoma multiforme-associated EGF receptor mutant possessing a duplicated kinase domain

(2009) B H Ozer et al.   ONCOGENE

Ginsenoside Rh2-mediated G1 Phase Cell Cycle Arrest in Human Breast Cancer Cells Is Caused by p15 Ink4B and p27 Kip1 -dependent Inhibition of Cyclin-dependent Kinases

(2009) Sunga Choi et al.   PHARMACEUTICAL RESEARCH